{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/sprains-strains/how-up-to-date-is-this-topic/changes/","result":{"pageContext":{"chapter":{"id":"e8bf3ab1-59f9-584b-ac22-b4726c553b25","slug":"changes","fullItemName":"Changes","depth":2,"htmlHeader":"<!-- begin field 15957ac5-7d0d-4ad3-9a84-dee48baf7b5e --><h2>Changes</h2><!-- end field 15957ac5-7d0d-4ad3-9a84-dee48baf7b5e -->","summary":null,"htmlStringContent":"<!-- begin item bb2bd47a-8927-43c6-bc40-c589450e1191 --><!-- begin field a42fd774-99ef-42a6-824f-37ce1a2a1242 --><p><strong>March to April 2020 </strong>— reviewed. A literature search was conducted in February 2020 to identify evidence-based guidelines, UK policy, systematic reviews, and key randomized controlled trials published since the last revision of the topic. The topic has undergone minor restructuring. The section on Prognosis and complications has been split into two separate sections, in line with current CKS style. The section on Arranging immediate referral has been deleted, and the content incorporated into the section on Management. The Prescribing information section has been deleted, and relevant links provided within the content of the Management section. Recommendations have been updated in line with current evidence, and minor changes to the recommendations on management have been made.</p><!-- end field a42fd774-99ef-42a6-824f-37ce1a2a1242 --><!-- end item bb2bd47a-8927-43c6-bc40-c589450e1191 -->","topic":{"id":"b73a9083-54f2-5b6c-8d60-49cc2551ff0f","topicId":"faa8bd48-669b-42a1-88f6-a6f5b62aa25e","topicName":"Sprains and strains","slug":"sprains-strains","lastRevised":"Last revised in April 2020","chapters":[{"id":"75389880-10d0-5c23-b8cc-31852071f60a","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"3cbf3015-bb75-5c2c-9eb0-746519dbaf56","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"066d4113-9dfb-5546-ad82-827b0ddaefd3","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"e8bf3ab1-59f9-584b-ac22-b4726c553b25","slug":"changes","fullItemName":"Changes"},{"id":"9520d1b6-f717-5a42-80d3-5ddab551943e","slug":"update","fullItemName":"Update"}]},{"id":"61666bab-551c-5e5d-bb34-8df3b67420af","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"c3e64a0d-b56e-5028-955f-0cc5184519f0","slug":"goals","fullItemName":"Goals"},{"id":"dfed68b3-14f3-508e-9e0e-efa3628bdff3","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"bc5b9107-4f2f-5e60-b270-5c07ed7431eb","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"c7dad6a2-99b8-5fa6-9e77-a0407c855cad","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"f56f3620-53af-50ca-8eb4-5c12c664e64c","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"ab3f2c2c-34a8-5dc4-b6a5-1a99c1ab8bde","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"7b4abc1a-68c8-5f27-9762-f380752cb605","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"16bf26eb-664f-56bc-834a-814960e48538","slug":"definition","fullItemName":"Definition"},{"id":"e455c0ed-d4e7-5ade-bc62-4b4665e7424c","slug":"risk-factors","fullItemName":"Risk factors"},{"id":"1d79c69d-ae5c-5f71-8500-5944c319b224","slug":"prevalence","fullItemName":"Prevalence"},{"id":"44dd8274-7adb-55da-b60c-fe08548efb9e","slug":"complications","fullItemName":"Complications"},{"id":"98ca4f1e-a1d4-5543-a7ca-da8e5ab60979","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"019337b0-fc4f-54a7-9eaf-803d066969d9","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"cbe522b2-4da0-56a4-82c6-55516a7d89b1","slug":"assessment","fullItemName":"Assessment"},{"id":"8ec4e760-f4a7-5214-a514-b31fe39672e6","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"56c51a98-369a-5a97-b96d-8dfef07fbf35","fullItemName":"Management","slug":"management","subChapters":[{"id":"f17e3a12-2343-5873-baa5-aabe4b93e869","slug":"management","fullItemName":"Scenario: Management"}]},{"id":"1e8afe6a-43e3-52ef-ace9-8c5f909158ee","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"586cfb98-fbb6-56e3-b0a1-6e56eef1ab6f","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"8060f49e-bb74-5884-afd5-91f5532cbf09","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"442eba80-3cb9-5376-930a-b7222d63ef9d","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"a520059a-eb8c-5cdd-b83b-f66d5469c500","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"34702cca-0ff4-5014-b859-c72a2c0f1718","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"2058daeb-9b82-5fd9-b53c-3267ca8b7949","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"cc0f89e0-2eb0-5cd4-a5a3-fb038ea830bc","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"066d4113-9dfb-5546-ad82-827b0ddaefd3","slug":"how-up-to-date-is-this-topic","fullItemName":"How up-to-date is this topic?"},"subChapters":[{"id":"509db554-261d-50a6-98a1-a1869df6d1b1","slug":"previous-changes","fullItemName":"Previous changes","depth":3,"htmlHeader":"<!-- begin field 5b7db5d6-9dea-4bcc-96ee-d1eacbb4459a --><h3>Previous changes</h3><!-- end field 5b7db5d6-9dea-4bcc-96ee-d1eacbb4459a -->","summary":null,"htmlStringContent":"<!-- begin item 051fa3f7-abd7-446b-9863-c07d5555e1f7 --><!-- begin field 5ac529e3-a7f0-4224-a481-8eccb26053da --><p><strong>March 2016 </strong>— reviewed. A literature search was conducted in February 2016 to identify evidence-based guidelines, UK policy, systematic reviews, and key randomized controlled trials published since the last revision of this topic. No major changes to recommendations have been made, but the topic has been restructured.</p><p><strong>April 2015 </strong>— minor update. A link to the CKS topic on Analgesia has been added.</p><p><strong>February 2014 </strong>— minor update. The prescribing information has been updated to reflect new information from the manufacturer of piroxicam gel regarding reports of renal adverse effects with piroxicam gel use.</p><p><strong>February 2013 </strong>— minor update. The 2013 QIPP options for local implementation have been added to this topic.</p><p><strong>October 2012 </strong>— reviewed. A literature search was conducted in September 2012 to identify evidence-based guidelines, UK policy, systematic reviews, and key randomized controlled trials published since the last revision of the topic. A change was made in the recommendations relating to specific management of severe sprains.</p><p><strong>May 2011 </strong>— minor update. The 2010/2011 QIPP options for local implementation have been added to this topic. Issued in June 2011.</p><p><strong>March 2011</strong>— topic structure revised to ensure consistency across CKS topics. No changes to clinical recommendations have been made.</p><p><strong>September 2010</strong> — minor update. The Medicines and Healthcare products Regulatory Agency (MHRA) has recently advised that topical ketoprofen is associated with a risk of photosensitivity reactions. Issued in September 2010.</p><p><strong>June 2009 </strong>— minor update. The Medicines and Healthcare products Regulatory Agency (MHRA) has recently reminded prescribers of the risk of photosensitivity reactions for people using topical ketoprofen. Issued in June 2009.</p><p><strong>March to July 2008</strong> — converted from CKS guidance to CKS topic structure. The evidence-base has been reviewed in detail, and recommendations are more clearly justified and transparently linked to the supporting evidence. There were no major changes to the recommendations.</p><p><strong>October 2006 </strong>— minor update. Analgesia prescriptions updated because new doses of ibuprofen for children are recommend by the British National Formulary (BNF). Issued in October 2006.</p><p><strong>July 2006 </strong>— minor update to drug rationales. Issued in July 2006.</p><p><strong>October 2005 </strong>— minor technical update. Issued in November 2005.</p><p><strong>July 2005 </strong>— update to text discussing nonsteroidal anti-inflammatory drugs (NSAIDs) in the <em>Medicines management </em>and <em>Prescribing points </em>sections. Issued in July 2005.</p><p><strong>January 2005 </strong>— reviewed. Validated in March 2005 and issued in April 2005.</p><p><strong>September 2001 </strong>— rewritten, with previous guidance on different types of sprains consolidated into one guidance on sprains in general. Validated in November 2001 and issued in April 2002.</p><p><strong>June 1998 </strong>— written.</p><!-- end field 5ac529e3-a7f0-4224-a481-8eccb26053da --><!-- end item 051fa3f7-abd7-446b-9863-c07d5555e1f7 -->","subChapters":[]}]}}},"staticQueryHashes":["3666801979"]}